Tim Wright, Editor, Contract Pharma11.07.17
Kevin Cook is the chief executive officer of Sterling Pharma Solutions and is responsible for strategically ensuring compliance, growth and profitability for the UK-based contract development and manufacturing organization (CDMO). He has over 30 years’ experience in the pharmaceutical industry, having worked at a number of CDMOs before joining Sterling in 1993. In January 2014, Kevin was appointed as president and in 2016, he led the business through a management buy-out (MBO) to form Sterling Pharma Solutions, which is now the largest independent API CDMO in the UK. He spoke with Contract Pharma recently about building and maintaining successful partnerships with sponsors in the outsourcing space.
Contract Pharma: How have outsourcing relationships evolved over the last ten years?
Kevin Cook: The key change across the API outsourcing space has been the notable shift from tactically outsourcing on a project basis to developing long-term strategic partnerships with contract providers. Often this is to access specialist expertise that pharmaceutical companies may not possess in-house, for example manufacturing potent APIs or
Contract Pharma: How have outsourcing relationships evolved over the last ten years?
Kevin Cook: The key change across the API outsourcing space has been the notable shift from tactically outsourcing on a project basis to developing long-term strategic partnerships with contract providers. Often this is to access specialist expertise that pharmaceutical companies may not possess in-house, for example manufacturing potent APIs or
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
